Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder

Schneier, F. R., Feusner, J., Wheaton, M. G., Gomez, G. J., Cornejo, G., Naraindas, A. M., & Hellerstein, D. J. (2023). Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. Journal of Psychiatric Research, 161, 364–370. https://doi.org/10.1016/j.jpsychires.2023.03.031
Authors:
Franklin R. Schneier
Jamie Feusner
Michael G. Wheaton
Gloria J. Gomez
Giselle Cornejo
Akansha Mahesh Naraindas
David J. Hellerstein
Affiliated Authors:
Franklin R. Schneier
David J. Hellerstein
Author Keywords:
body dysmorphic disorder
clinical trial
hallucinogen
psilocybin
Publication Type:
Article
Unique ID:
10.1016/j.jpsychires.2023.03.031
PMID:
Publication Date:
Data Source:
Scopus

Record Created: